Cipla, Dr Reddy’s, Viatris And Teva Named In US Revlimid Antitrust Suit

ANDA Sponsors ‘Restrained Competition And Maintained Shared Monopoly’

 
• By Dean Rudge
  
US flag gavel (Andriy Popov/Alamy Stock Photo)
Defendant Dr Reddy's says the suit is without merit • Source: Shutterstock (Andriy Popov / Alamy Stock Photo/Alamy Stock Photo)
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin